Sorry, you need to enable JavaScript to visit this website.
Skip to main content

Our Management

Location Settings

Asia-Pacific

AU -  Sydney
AU -  Melbourne
AU -  Brisbane
CN -  Hong Kong
CN -  Shanghai
IN -  Bangalore
MY -  Kuala Lumpur
PH -  Metro Manila
KR -  Seoul
CN -  Taipei City
TH -  Bangkok
NZ -  New Zealand

North America

US -  San Francisco
US -  Boston

GLOBAL

English

CAREERS

SOLUTIONS

RESOURCES

ABOUT US

Location Settings

Asia-Pacific

AU -  Sydney
AU -  Melbourne
AU -  Brisbane
CN -  Hong Kong
CN -  Shanghai
IN -  Bangalore
MY -  Kuala Lumpur
PH -  Metro Manila
KR -  Seoul
CN -  Taipei City
TH -  Bangkok
NZ -  New Zealand

North America

US -  San Francisco
US -  Boston

GLOBAL

English

Board OF DIRECTORS

Anand Tharmaratnam

Anand Tharmaratnam

Chairman
Anand Tharmaratnam

Anand Tharmaratnam

Chairman

Anand brings over 20 years of experience in global drug development and the CRO industry. He was previously the president of Asia Pacific at IQVIA. Anand is a medical doctor by training and graduated from the University College London, UK and trained in the anaesthesia.

Photo of Joel Thickins

Joel Thickins

Board Member
Photo of Joel Thickins

Joel Thickins

Board Member

Joel is a Partner at TPG Capital and leads the firm’s investment program in the ANZ region as Head of Australia and New Zealand. Joel has previously served on the board of Inghams Group Limited and Accolade Wines Holding Australia Pty Limited.

Before joining TPG, Joel was a director at CPE Capital (formerly known as CHAMP Private Equity) where he was responsible for the company’s activities in the industrial, agricultural services and consumer markets.

Dr. Fred Cohen

Dr. Fred Cohen

Board Member
Dr. Fred Cohen

Dr. Fred Cohen

Board Member

Fred Cohen is a Senior Advisor to TPG and was a partner and co-founder of TPG Biotech. Fred has served on the board of several biotech and pharmaceutical organizations including BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) and CareDx, Inc. (NASDAQ: CDNA)

 Vincent Wong

Vincent Wong

Board Member
 Vincent Wong

Vincent Wong

Board Member

Vincent Wong is a Managing Director with TPG Capital and is based in Melbourne, where he works in TPG’s Australian team. Prior to joining TPG in 2011, Vincent served in the corporate advisory division at Goldman Sachs Australia. Vincent graduated from the University of Melbourne with BCommerce and BLaws (Honors).

 Lydia Cai

Lydia Cai

Board Member
 Lydia Cai

Lydia Cai

Board Member

Lydia Cai is a Managing Director with TPG Capital based in Beijing and leads TPG’s healthcare investments in the Greater China area. Prior to joining TPG in 2011, Lydia was an investment associate at HAO Capital, a China-focused early stage private equity fund focusing on growth-stage healthcare investments.

John Moller

John Moller

Chief Executive Officer
John Moller

John Moller

Chief Executive Officer

John joined Novotech in January 2014 to lead the development of Novotech’s Asia operations. Prior to Novotech John was Managing Director of IVF Australia and Queensland Fertility Group and sat on the Board of Virtus Health Limited. John is a medical doctor by training.

Senior Management

John Moller

John Moller

Chief Executive Officer
John Moller

John Moller

Chief Executive Officer

John joined Novotech in January 2014 to lead the development of Novotech’s Asia operations. Prior to Novotech John was Managing Director of IVF Australia and Queensland Fertility Group and sat on the Board of Virtus Health Limited. John is a medical doctor by training.

Michael stibilj

Michael stibilj

Chief Operating Officer
Michael stibilj

Michael stibilj

Chief Operating Officer

Michael has 25 years of experience in the CRO Industry. Prior to joining Novotech in 2017, Michael spent 15 years building and leading operations across Asia for Quintiles/IQVIA, and was senior advisor for TPG Capital.

Zidong

Zidong Zhang

Group Chief Finance Officer
Zidong

Zidong Zhang

Group Chief Finance Officer

Zidong Zhang is responsible for all aspects of financial management to support the growth of Novotech across Asia. Prior to joining Novotech, Dr. Zhang was CFO at Shanghai Henlius Biotech, Inc. a Hong Kong-listed global biopharmaceutical company based in Shanghai, where he built and managed the finance team and played an integral role in the company’s initial public offering in 2019. Prior to that, Dr. Zhang was an equity research analyst at UBS in New York, where he covered the United States large cap pharmaceutical and specialty pharmaceutical sector.

Barry Murphy

Barry Murphy

Chief Commercial Officer
Barry Murphy

Barry Murphy

Chief Commercial Officer

Barry joined in July 2014 to lead the growth of Novotech’s Business Development team. Barry started his career as a pharmacist having graduated from the University of Dublin. He has held multiple contract management roles at ICON plc.

Andy Liu

Andy Liu

Head of China
Andy Liu

Andy Liu

Head of China

Andy worked at Covance, Inc., a global CRO, for more than 10 years in a number of executive positions. Most recently, he was General Manager of Covance's Central Laboratory Service, Asia Pacific, where he led a large multi-functional team of across multiple sites in APAC. Andy holds an MBA from the University of Chicago, an MS in Electrical Engineering from the Rose-Hulman Institute of Technology, and a BS in Electrical Engineering from Tsinghua University.

Veronica Holloway

Veronica Holloway

Chief Legal and Compliance Officer
Veronica Holloway

Veronica Holloway

Chief Legal and Compliance Officer

Veronica joined Novotech in May 2014 to formalise the legal function at Novotech. Prior to Novotech, Veronica held roles as Senior Legal Counsel at EY, Senior Solicitor at Clayton Utz and General Counsel (on secondment) at Novartis Pharmaceuticals Australia Pty Limited. Veronica holds a BA/LLB/LLM.

Angela Edwardson

Angela Edwardson

Chief People Officer
Angela Edwardson

Angela Edwardson

Chief People Officer

Angela joined Novotech in November 2015 and is responsible for Novotech's Human Resources operations including strategy, organisational development, remuneration & reward and workplace health and safety. Angela is passionate about delivering Novotech's vision of being the leading CRO in the Asia Pacific region.